Carregant...

Reduced Mortality and Severe Disability Rates in the SENTIS Trial

BACKGROUND AND PURPOSE: The Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke trial showed a trend for reduced all-cause mortality and positive secondary safety end point outcomes. We present further analyses of the mortality and severe disability data from the Safety and Efficacy of Neu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Schellinger, P.D., Shuaib, A., Köhrmann, M., Liebeskind, D.S., Jovin, T., Hammer, M.D., Sen, S., Huang, D.Y., Solander, S., Gupta, R., Leker, R.R., Saver, J.L.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Neuroradiology 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4156593/
https://ncbi.nlm.nih.gov/pubmed/23828106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A3613
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!